Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
167,3 EUR | -1,02 % | +0,36 % | +16,45 % |
23/05 | MERCK KGAA : UBS toujours à l'achat | ZD |
23/05 | Merck KGaA : acquisition de l'américain Mirus Bio | CF |
Métier
- solutions et produits pour les recherches scientifiques et biotechnologiques (44,2%) ;
- produits pharmaceutiques (38,4%) : médicaments prescrits sous ordonnance destinés au traitement du diabète, du cancer, de la sclérose en plaques, de l'infertilité, des maladies cardiovasculaires, des troubles du système nerveux central, des troubles inflammatoires, etc. ;
- matériaux de performance pour l'industrie électronique (17,4%) : matériaux semi-conducteurs, cristaux liquides, pigments et additifs, matériaux organiques à base de carbone, etc.
La répartition géographique du CA est la suivante : Allemagne (4,8%), Europe (24%), Chine (12,9%), Asie-Pacifique (20,1%), Etats-Unis (26,8%), Amérique du Nord (1,6%), Amérique latine (6,3%), Moyen Orient et Afrique (3,5%).
Nombre d'employés: 62 345
Ventes par activité
EUR en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Life Science
44,2
%
| 10 380 | 46,7 % | 9 281 | 44,2 % | -10,59 % |
Healthcare
38,4
%
| 7 839 | 35,3 % | 8 053 | 38,4 % | +2,73 % |
Electronics
17,4
%
| 4 013 | 18,1 % | 3 659 | 17,4 % | -8,82 % |
Ventes par région
EUR en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
28,2
%
| 6 302 | 28,3 % | 5 911 | 28,2 % | -6,20 % |
Europe
21,0
%
| 4 524 | 20,3 % | 4 402 | 21,0 % | -2,70 % |
Asia Pacific
19,9
%
| 4 479 | 20,1 % | 4 181 | 19,9 % | -6,65 % |
China
11,8
%
| 2 818 | 12,7 % | 2 477 | 11,8 % | -12,10 % |
Germany
6,8
%
| 1 532 | 6,9 % | 1 420 | 6,8 % | -7,31 % |
Latin America
6,0
%
| 1 175 | 5,3 % | 1 267 | 6,0 % | +7,83 % |
Middle East and Africa
2,5
%
| 516 | 2,3 % | 535 | 2,5 % | +3,68 % |
Switzerland
2,4
%
| 592 | 2,7 % | 512 | 2,4 % | -13,51 % |
North America
1,4
%
| 294 | 1,3 % | 287 | 1,4 % | -2,38 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 62 | 13/07/20 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01/08/14 |
Director of Finance/CFO | 53 | 26/04/19 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/19 |
Danny Bar-Zohar
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/20 |
Constantin Fest
IRC | Investor Relations Contact | - | - |
Jeff White
PRN | Corporate Officer/Principal | - | - |
Andrew Paterson
SAM | Sales & Marketing | - | - |
Corporate Officer/Principal | - | 01/09/21 | |
Hong Chow
PRN | Corporate Officer/Principal | 53 | 01/01/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 75 | 09/05/14 | |
Chairman | 67 | 26/04/19 | |
Jürgen Glaser
BRD | Director/Board Member | 61 | 01/05/12 |
Alexander Putz
BRD | Director/Board Member | 47 | 01/01/85 |
Director of Finance/CFO | 53 | 26/04/19 | |
Barbara Lambert
BRD | Director/Board Member | 62 | 11/08/23 |
Sascha Held
BRD | Director/Board Member | - | 26/04/19 |
Renate Koehler
BRD | Director/Board Member | - | 26/04/19 |
Anne Lange
BRD | Director/Board Member | - | 26/04/19 |
Daniel Thelen
BRD | Director/Board Member | - | 26/04/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 305 535 626 | 0 | 0 | 29,71 % |
Action B | 1 | 129 242 252 | 129 159 619 ( 99,94 %) | 0 |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
2 787 509 | 4,65% | 117 772 255 $ | |
PT MERCK TBK 86,65% | 388 194 920 | 86,65% | 97 405 869 $ |
VERA THERAPEUTICS, INC. 3,48% | 1 913 501 | 3,48% | 74 033 354 $ |
PRECIGEN, INC. 8,29% | 20 647 152 | 8,29% | 28 906 013 $ |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Ridgefield Holdco SARL
| |
Merck Specialities Pvt Ltd.
Merck Specialities Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Specialities Pvt Ltd. is a pharmaceutical manufacturing and Indian distribution company. The company is based in Mumbai, India and was founded in 2005. |
Pharmaceuticals: Major
|
Merck Finanz SARL
Merck Finanz SARL Medical/Nursing ServicesHealth Services Part of Merck KGaA, Merck Finanz SARL is a Luxembourger company that provides healthcare, life sciences, and electronic services. The company is based in Luxembourg, Luxembourg. |
Medical/Nursing Services
|
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. |
Medical Specialties
|
Merck Electronics KGaA
| |
Merck Life Science UK Ltd.
Merck Life Science UK Ltd. Chemicals: Major DiversifiedProcess Industries Founded in 1960, Merck Life Science UK Ltd. is a subsidiary of Merck KGaA. The company is based in Gillingham, UK. The British company provides advanced chemical materials for the manufacturing of LCD panels. |
Chemicals: Major Diversified
|
Merck BV
| |
Merck Life Science A/S
Merck Life Science A/S Electronic Equipment/InstrumentsElectronic Technology Part of Merck KGaA, Merck Life Science A/S is a Danish company that provides industrial instruments for measurement. The company is located in Denmark. |
Electronic Equipment/Instruments
|
Merck Santé SASU
Merck Santé SASU Pharmaceuticals: MajorHealth Technology Merck Santé SAS manufactures pharmaceutical products. The company is headquartered in Lyon, France. |
Pharmaceuticals: Major
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+16,45 % | 79,55 Md | |
+8,35 % | 8,79 Md | |
-15,14 % | 4,88 Md | |
+50,73 % | 4,73 Md | |
+4,36 % | 3,92 Md | |
-26,13 % | 2,2 Md | |
+12,01 % | 2,28 Md | |
+16,45 % | 2,11 Md | |
-33,59 % | 2,08 Md | |
-0,50 % | 1,64 Md |
- Bourse
- Actions
- Action MRK
- Société Merck KGaA